<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827358/" ref="ordinalpos=1327&amp;ncbi_uid=5486255&amp;link_uid=PMC3827358" image-link="/pmc/articles/PMC3827358/figure/pone-0079350-g008/" class="imagepopup">Figure 8. Schematic illustration of the <span class="highlight" style="background-color:">signaling</span> <span class="highlight" style="background-color:">pathway</span> involved in the inhibitory effect of LPS on Cx43 gap junctions in rat astrocytes..  From: Lipopolysaccharide Induces Degradation of Connexin43 in Rat Astrocytes via the Ubiquitin-Proteasome Proteolytic <span class="highlight" style="background-color:">Pathway</span>. </a></div><br /><div class="p4l_captionBody">LPS treatment down-regulates caveolin-3 levels via TLR4-mediated iNOS activation, which in turn reduces the expression of Cx43. LPS also induces JNK phosphorylation, resulting in GJIC inhibition, gap junction disassembly, and Cx43 degradation by the ubiquitin-proteasome proteolytic pathway.</div></div>